BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 27926694)

  • 1. Involvement of Activated Cdc42 Kinase1 in Colitis and Colorectal Neoplasms.
    Lv C; Zhao X; Gu H; Huang L; Zhou S; Zhi F
    Med Sci Monit; 2016 Dec; 22():4794-4802. PubMed ID: 27926694
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory bowel disease in Ashkenazi Jews: implications for familial colorectal cancer.
    Lynch HT; Brand RE; Locker GY
    Fam Cancer; 2004; 3(3-4):229-32. PubMed ID: 15516846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer complicating inflammatory bowel disease: similarities and differences between Crohn's and ulcerative colitis based on three decades of experience.
    Kiran RP; Khoury W; Church JM; Lavery IC; Fazio VW; Remzi FH
    Ann Surg; 2010 Aug; 252(2):330-5. PubMed ID: 20622662
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IBD-Associated Dysplastic Lesions Show More Chromosomal Instability Than Sporadic Adenomas.
    Wanders LK; Cordes M; Voorham Q; Sie D; de Vries SD; d'Haens GRAM; de Boer NKH; Ylstra B; van Grieken NCT; Meijer GA; Dekker E; Carvalho B
    Inflamm Bowel Dis; 2020 Jan; 26(2):167-180. PubMed ID: 31372648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
    Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
    Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of ATF6 as a marker of pre-cancerous atypical change in ulcerative colitis-associated colorectal cancer: a potential role in the management of dysplasia.
    Hanaoka M; Ishikawa T; Ishiguro M; Tokura M; Yamauchi S; Kikuchi A; Uetake H; Yasuno M; Kawano T
    J Gastroenterol; 2018 May; 53(5):631-641. PubMed ID: 28884228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn's disease from ulcerative colitis.
    Tanaka M; Riddell RH; Saito H; Soma Y; Hidaka H; Kudo H
    Scand J Gastroenterol; 1999 Jan; 34(1):55-67. PubMed ID: 10048734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polypoid dysplasia and adenomas in inflammatory bowel disease: a clinical, pathologic, and follow-up study of 89 polyps from 59 patients.
    Torres C; Antonioli D; Odze RD
    Am J Surg Pathol; 1998 Mar; 22(3):275-84. PubMed ID: 9500769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Morphological, immunohistochemical and molecular features of inflammatory bowel disease associated colorectal carcinoma and associated mucosal lesions - Single institution experience.
    Kamarádová K; Vošmiková H; Rozkošová K; Ryška A; Tachecí I; Laco J
    Pathol Res Pract; 2019 Apr; 215(4):730-737. PubMed ID: 30679085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
    Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP
    Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal neoplasia in Crohn's colitis: a retrospective comparative study with ulcerative colitis.
    Svrcek M; Cosnes J; Beaugerie L; Parc R; Bennis M; Tiret E; Fléjou JF
    Histopathology; 2007 Apr; 50(5):574-83. PubMed ID: 17394493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similarities and differences in clinical and pathologic features of inflammatory bowel disease-associated colorectal cancer in China and Canada.
    Li J; Zhou WX; Liu S; Zheng WY; Wang YN; Li JN; Ferraz JG; Qian JM; Gui XY
    Chin Med J (Engl); 2019 Nov; 132(22):2664-2669. PubMed ID: 31725457
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inactivation of JNK2 as carcinogenic factor in colitis-associated and sporadic colorectal carcinogenesis.
    Lessel W; Silver A; Jechorek D; Guenther T; Roehl FW; Kalinski T; Roessner A; Poehlmann-Nitsche A
    Carcinogenesis; 2017 May; 38(5):559-569. PubMed ID: 28383667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colitis-associated DNA aneuploidy and dysplasia in Crohn's disease and risk of colorectal cancer.
    Söderlund S; Tribukait B; Öst Å; Broström O; Karlén P; Löfberg R; Askling J; Sjöqvist U
    Inflamm Bowel Dis; 2011 May; 17(5):1101-7. PubMed ID: 20853434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced expression of MMP-7 and MMP-13 in inflammatory bowel disease: a precancerous potential?
    Rath T; Roderfeld M; Graf J; Wagner S; Vehr AK; Dietrich C; Geier A; Roeb E
    Inflamm Bowel Dis; 2006 Nov; 12(11):1025-35. PubMed ID: 17075343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Pathobiology of dysplasia in chronic inflammatory bowel disease: Current recommendations for surveillance of dysplasia].
    Raithel M; Weidenhiller M; Schwab D; Müller S; Hahn EG
    Z Gastroenterol; 2001 Oct; 39(10):861-75. PubMed ID: 11605156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High Adherence to Surveillance Guidelines in Inflammatory Bowel Disease Patients Results in Low Colorectal Cancer and Dysplasia Rates, While Rates of Dysplasia are Low Before the Suggested Onset of Surveillance.
    Singh K; Al Khoury A; Kurti Z; Gonczi L; Reinglas J; Verdon C; Kohen R; Bessissow T; Afif W; Wild G; Seidman E; Bitton A; Lakatos PL
    J Crohns Colitis; 2019 Sep; 13(10):1343-1350. PubMed ID: 30918959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotensin receptor 1 overexpression in inflammatory bowel diseases and colitis-associated neoplasia.
    Gui X; Liu S; Yan Y; Gao Z
    World J Gastroenterol; 2013 Jul; 19(28):4504-10. PubMed ID: 23901225
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endoscopy/surveillance in inflammatory bowel disease.
    Ahmadi AA; Polyak S
    Surg Clin North Am; 2007 Jun; 87(3):743-62. PubMed ID: 17560423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomic Alterations Observed in Colitis-Associated Cancers Are Distinct From Those Found in Sporadic Colorectal Cancers and Vary by Type of Inflammatory Bowel Disease.
    Yaeger R; Shah MA; Miller VA; Kelsen JR; Wang K; Heins ZJ; Ross JS; He Y; Sanford E; Yantiss RK; Balasubramanian S; Stephens PJ; Schultz N; Oren M; Tang L; Kelsen D
    Gastroenterology; 2016 Aug; 151(2):278-287.e6. PubMed ID: 27063727
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.